Who owns the OZALIN trademark?

The OZALIN trademark is owned by Primex Pharmaceuticals AG.

What class is the OZALIN trademark registered in?

The OZALIN trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for OZALIN?

The USPTO serial number for OZALIN is 79422037.

What is the registration number for OZALIN?

OZALIN is registered under USPTO registration number 8200321.

Sealvo

Home Search: OZALINOZALIN #79422037

Back

Updated Oct 22, 2026·22 searches this week

View on USPTO TSDR Find similar marks

OZA

USPTO Trademark Record

REGISTERED

OZALIN

SN 79422037·Reg 8200321·Filed Mar 21, 2025

Owner Primex Pharmaceuticals AG

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

OZALIN (Serial No. 79422037), Registration No. 8200321, is a registered US trademark filed on Mar 21, 2025 by Primex Pharmaceuticals AG. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: April 07, 2032

Mark Intelligence

OZALIN (Reg. #8200321) is a registered US trademark that has been protecting its owner, Primex Pharmaceuticals AG, since 2025. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 4 opposition proceedings during prosecution.

FILED

Mar 21, 2025

SERIAL

79422037

REG#

8200321

REGISTERED

Apr 07, 2026

Filing Information

StatusREGISTERED

Filing DateMar 21, 2025

Serial Number79422037

Registration No.8200321

Registration DateApr 07, 2026

Status DateApr 07, 2026

Published for OppositionFeb 17, 2026

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

26 events

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Oct 01, 2026

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

FINAL DECISION TRANSACTION PROCESSED BY IB

Oct 01, 2026

FINAL DECISION TRANSACTION PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Sep 16, 2026

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Sep 16, 2026

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

FINAL DISPOSITION PROCESSED

Sep 13, 2026

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Sep 13, 2026

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jul 07, 2026

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Apr 07, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 07, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Feb 17, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 17, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 11, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 22, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 19, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 19, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 19, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Oct 31, 2025

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Oct 08, 2025

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Oct 08, 2025

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Aug 26, 2025

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Aug 25, 2025

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Aug 20, 2025

ASSIGNED TO EXAMINER

LIMITATION FROM ORIGINAL APPLICATION ENTERED

May 05, 2025

LIMITATION FROM ORIGINAL APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 05, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

May 05, 2025

APPLICATION FILING RECEIPT MAILED

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Apr 17, 2025

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Other Marks by Primex Pharmaceuticals AG

Additional USPTO filings from the same owner.

OZA

OZASED

79444259

Primex Pharmaceuticals AG

PENDING

OZA

OZASED

79258305

Primex Pharmaceuticals AG

ABANDONED

OZA

OZALIN

79242424

Primex Pharmaceuticals AG

ABANDONED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

OZA

OZALIN

79242424

Primex Pharmaceuticals AG

ABANDONED

Other Marks by Elizabeth A. Cominolli

Additional USPTO filings handled by the same attorney of record.

VIT

VITREQ

79181091

REGISTERED

GEI

GEISHA

79191789

REGISTERED

QUA

QUANTIPARTS

79168858

REGISTERED

XQU

XQUICK

79418975

REGISTERED

OZALIN

Run a conflict check

Other Marks by Primex Pharmaceuticals AG

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Elizabeth A. Cominolli

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company